Clinician’s perspective for personalized medicine and genetic testing as the future of cancer diagnosis

Journal Title: Stanley Medical Journal - Year 2016, Vol 3, Issue 3

Abstract

Molecular diagnostics offer a promise of reducing the length, cost and uncertainty of new molecular entities and potentially unlocking targets for precision medicine through: patient susceptibility to disease; patient respond to treatment or any adverse events; disease progression; proof-of-concept targets correct pathway and success of treatment. Molecular diagnostic tests have emerged as one of the successful means for providing critical insights about disease diagnostics and treatment. The personalized medicine is becoming a reality not only for precise diagnosis but also providing targets towards development of successful therapy for cancer patients. To ensure that new therapies are delivered to the right patients through accurate diagnosis, it is essential to adopt the recommendations for molecular diagnostics as well as therapeutics. Molecular biomarkers can not only serve as predictive for clinical management of cancer but also provide a hope for targeted therapy. With the cost of genomic technologies coming down and results are more clinically relevant, it is possible to predict precise genetic variations that occur in cancer patients. However, awareness is required to reduce cost phenomenally altering cancer management in a better way. To make it reality consortium of oncologists is recommended for development of Indian patient specific biomarker study

Authors and Affiliations

Anita Ramesh, Subbu Apparsundaram, Karthikeyan Rajamani, Ramesh K Goyal

Keywords

Related Articles

UHL’S ANOMALY- A RARE CARDIAC MALFORMATION

Uhl’s anomaly is an exceedingly rare congenital cardiac malformation characterized by complete or partial absence of the right ventricular myocardium. This could be attributed to alternations during embryological develop...

SUBCUTANEOUS FAT NECROSIS OF NEWBORN WITH ASYMPTOMATIC HYPERCALCEMIA.

A 9 day old male baby born of consanguinous marriage postmaturely by labour naturale was admitted for birth asphyxia and meconium aspiration in NICU for a week developed multiple erythematous nodules over the back, butto...

Correlation of Agaston Score in Obstructive and Non-obstructive Coronary Artery Disease following ST segment elevation Myocardial Infarction

The purpose of the study is to compare coronary artery calcium score in patients with Obstructive & Non obstructive coronary artery disease CAD and to compare coronary artery calcium score in patients with single & multi...

A STUDY ON ASSOCIATION BETWEEN CIGARETTE SMOKING AND GASTRIC CANCER

Objective: The study was aimed at assessing the association of smoking with gastric cancer since gastric cancer remains to be one of the leading causes of death from cancer worldwide in spite of advanced treatment modali...

FANCONI BICKEL SYNDROME- DIAGNOSTIC DILEMMAS AND CONTINUING MANAGEMENT CHALLENGES IN INDIAN SCENARIO

Fanconi Bickel syndrome (FBS) is a rare type of Glycogen storage disorder (TYPE XI) characterized by Hepatorenal glycogen accumulation, proximal renal tubular acidosis with Impaired glucose utilization. Though western wo...

Download PDF file
  • EP ID EP217342
  • DOI -
  • Views 91
  • Downloads 0

How To Cite

Anita Ramesh, Subbu Apparsundaram, Karthikeyan Rajamani, Ramesh K Goyal (2016). Clinician’s perspective for personalized medicine and genetic testing as the future of cancer diagnosis. Stanley Medical Journal, 3(3), 119-127. https://europub.co.uk/articles/-A-217342